Menu

  • RA-associated interstitial lung disease (RA-ILD).
  • Pleural disease (pleural thickening/effusions).
  • Airway disease (Both upper & lower airway).
  • Rheumatoid nodules
  • Drug-induced lung toxicity (i.e., Methotrexate-induced lung injury)
  • Fibro-bullous disease
  • Thoracic cage immobility
  • Venous thromboembolic disease
  • Vasculitis
  • Pneumonia.
RHEUMATOID EFFUSION:
  • WCC <5000/mm3
  • Fluid glucose <60 mg/Dl
  • Pleural fluid to serum glucose ratio < 0.5
  • pH < 7.3
  • High pleural LDH level (ie, > 700 IU/L)
  • Cytology: Slender or elongated multinucleated macrophages, round giant multinucleated macrophages, and necrotic background debris.
Pulmonary function testing in ILD (PFT):
  • Reduced VC, lung volumes, & DLCO.
  • Oxygen desaturation during exercise.
  • Restrictive abnormalities common (poor muscle strength or kyphosis due to osteoporosis rather than ILD).


 

  • Indicator of kidney damage and / or a biomarker of systemic diseases dates back to 1969, when elevated albumin levels were first demonstrated in the urine of patients with newly diagnosed diabetes.
  • Urine dipstick is a relatively insensitive marker for albuminuria, not becoming positive until albumin excretion exceeds 300-500 mg/day. 
  • Normal rate of albumin excretion is < 30 mg/day (20 mcg/min).
  • Persistent albumin excretion between 30-300 mg/day (20 to 200 mcg/min) is called moderately increased albuminuria (formerly called "microalbuminuria").
  • Excretion > 300 mg/day (200 mcg/min) represents overt or dipstick positive proteinuria (severely increased albuminuria [formerly called "macroalbuminuria"].
  • Albuminuria reflects functional and / or structural changes in the glomerular filtration membrane that allow increased leakage of albumin into primary urine in amounts exceeding the reabsorption capacity of the proximal nephron tubules. 
  • Albuminuria considered as an indicator of early damage (dysfunction) of the vascular endothelium (including the glomerular vessels), which leads to increased permeability of the vascular wall. 
  • Relationship between albuminuria and cardiovascular risk has been shown in studies of the general population. 
  • It is linear and risk is independent of eGFR. 
  • Associated with arterial stiffness assessed by the pulse wave velocity measurement







  • Cytoplasmic enzymes present in tissues throughout the body.
  • Oxidoreductase, enzyme of the anaerobic metabolic pathway.
  • Heart, muscle, kidney, lung, and RBC’s have the highest concentration.
  • Upon tissue damage, the cells release LDH in the bloodstream.
  • Drugs that can increase LDH include alcohol, aspirin, fluorides, narcotics, anesthetics, clofibrate, mithramycin, and procainamide.
  • Cancer cells employ LDH to increase their aerobic metabolism (glycolysis, ATP production, & lactate production): Warburg effect.
  • CSF LDH increases in bacterial meningitis (normal in viral meningitis).
  • Cancer cells undergo LDH mediated energy production to fulfill the demand for fast cellular growth (marker of metastases, prognosis, survival rates., and radiosensitivity).
  • LDH serves as a general indicator of acute and chronic diseases.
  • LDH helps in distinguishing exudate from transudate effusions.
  • Isozymes, named LDH-1 through LDH-5, have differential expression in different tissues.

 

Role of Bile acids

  • Bile acids play a key role in the absorption of lipids in the small intestine. 
  • Contribute to cholesterol metabolism by promoting the excretion of cholesterol. 
  • Denature dietary proteins, thereby accelerating their breakdown by pancreatic proteases. 
  • Direct and indirect antimicrobial effects. In this capacity, recent evidence suggests bile acids are mediators of high-fat diet-induced changes in the gut microbiota. 
  • Act as signaling molecules outside of the gastrointestinal tract.

The primary bile acids—cholic acid and cheno-deoxycholic acid—are synthesized from cholesterol in the liver.

The maximal rate of bile acid synthesis is on the order of 4 to 6 g/day.



Horseshoe kidneys are often asymptomatic with incidence of approximately 1 in 500 in the normal population with a male preponderance of 2:1.

The isthmus connecting the two renal masses may be positioned in the midline or laterally resulting in an asymmetric horseshoe kidney, 70% of which are left dominant.

The isthmus consists of renal parenchyma in about 80% of cases with the remainder being composed of a fibrous band.

In more than 90% of cases, fusion occurs at the lower pole, although fusion may occur at the upper pole in a small minority of cases.

Higher incidence of UPJ obstructions, nephrolithiasis, and reflux compared to the general population. Increased frequency of some common renal cancers including transitional cell tumors (three to four times more common), Wilms tumor (twice as frequently), and an extremely large increase in very rare tumors such as carcinoid (62 to 82 times).






Autosomal Dominant, M = F, by 60 yrs-50% need renal replacement therapy

Multisystem & progressive disease with cysts formation

Kidney enlargement with other organ involvement (liver∼ 80%, pancreas 7-36%, spleen)

Intracranial aneurysms in ∼6% of pts without family history & ∼20% with a family history (rupture in 65-75%, usually before age 50)

Cardiac Valve abnormalities in 25-30%








  • First sensation of bladder filling at 100–150ml in an adult.
  • Feeling of need to pee at 200 - 350 ml of urine
  • Can comfortably hold between 300 - 450 ml
  • Wall pressure of 5 - 15 mm Hg creates a sensation of bladder fullness while 30 mm Hg & beyond is painful.
  • Most people pee 6 or 7 times/ 24 hours (4 -10 times daily is healthy).
  • Normal 24-hour Urine output is 800 - 2000 ml/day (at normal fluid intake of about 2 liters/day).





Calot's triangle is a small (potential) triangular space at the porta hepatis of surgical importance as it is dissected during cholecystectomy. Its contents, the cystic artery and cystic duct must be identified before ligation and division to avoid intraoperative injury.

Borders

  • Medial – common hepatic duct.
  • Inferior – cystic duct.
  • Superior – inferior surface of the liver.

The above differ from the original description of Calot’s triangle in 1891 – where the cystic artery is given as the superior border of the triangle. The modern definition gives a more consistent border (the cystic artery has considerable variation in its anatomical course and origin).

Contents

  • Right hepatic artery
  • Cystic artery
  • Cystic lymph node (of Lund)
  • Connective tissue

  • Lymphatics
  • Occasionally accessory hepatic ducts and arteries

Significance

  • Cystic artery arises from Right Hepatic Artery in the Calot's triangle in 75%
  • Cystic artery origin & course vary in 25% of population.

IV/IM admin of cosyntropin (250 μg), with collection of serum & measurement of cortisol at baseline & 30–60 min post stimulation.

Supra-physiological dose stimulates the pituitary & releases cortisol from the adrenal cortex, as long as the adrenal cortex has a functional reserve.

Factors affecting ACTH stim test interpretation:

  • Falsely negative or normal in mild disease or disease of recent onset.
  • Most common- false-positive test is seen in recent use of corticosteroids
  • Exogenous steroids lead to both baselines &adrenal responsiveness to cosyntropin.
  • Propofol impairs adrenal steroidogenesis
  • Midazolam, morphine, and fentanyl blunt the HPA axis, thereby interfering with corticosteroid metabolism.
  • Metyrapone, etomidate, ketoconazole, megesterol, & mitotate interfere with cosyntropin function.
  • Rifampin & phenytoin may increase cortisol metabolism.

In females, response to ACTH may be affected OCs which increase CBG levels.

  • Salivary cortisol response can be useful as their measurement is a surrogate for serum free cortisol & are not affected by OCs
  • Opioid receptors are present in the pituitary gland & hypothalamus, & opioids may impact HPA function.
  • Nenke et al studied 17 pts treated with long-term opioids. Five of the 17 (29%) were found to have evidence of AI, with cortisol levels of <5 μg/dL.




 

In patients ≥65 years of age treated with medication for type 2 diabetes, hemoglobin A1c values of 7%–8% have shown the greatest reduction in mortality in multiple studies. The specific hemoglobin A1c target between 7% and 8% should be based on shared decision-making and the overall condition of the patient at that specific age, with goals in the lower 7% range for those with good to excellent functional status. It is suggested that lower hemoglobin A1c values are associated with frequent hypoglycemia, which presents a greater risk than a higher hemoglobin A1c value alone. Hemoglobin A1c values over 9% are associated with greater mortality. Thus, while the risk of complications increases linearly with hemoglobin A1c, mortality has a U-shaped curve. Management of blood pressure and treatment with statins improves mortality in these patients as well and is important in addressing overall cardiovascular risk.



 

Xanthogranulomatous pyelonephritis is an uncommon, severe, subacute, or chronic suppurative process characterized by destruction and replacement of the renal parenchyma by granulomatous tissue containing histocytes and foamy cells. It is most often associated with chronic obstruction and stones with ongoing infection. It is also referred to as a pseudotumor due to an enlarged kidney resembling a tumor and the ability of local invasion and destruction.

The etiology remains unknown. However, most of the cases result from chronic urinary obstruction and infection. The organisms most commonly associated with XGP are Escherichia coli, Proteus mirabilis, Pseudomonas, Enterococcus faecalis, and Klebsiella, etc. Urinary obstruction occurs as a result of calculus, most commonly, staghorn calculus (in almost 80% of patients), which serves as a nidus for infection resulting in the destruction of the renal parenchyma.




 

Defined as neoplastic lesion in the periumbilical region arising as a primary tumor or representing as a site of metastasis from visceral organ malignancies such as from the gastrointestinal tract and the reproductive organs. The overall incidence is 1-3% in general population with malignancies. The primary site of malignancy associated is significantly different in men and women. The most common primary site in men is the stomach followed by the colon and pancreas, whereas in women, the most common site is the ovary followed by endometrium, colorectal, and pancreas.

The prognosis of patients presenting with Sister Mary Joseph’s nodule is generally poor as it is a sign of advanced malignancy. Management of the disease should consider patient preference, the clinical state of the patient, and the etiology of the primary malignancy.






Disclaimer

The compendium of content enshrined within this website—including its lexical compositions, pictorial representations, and adjunctive materials—is exclusively proffered for erudition and cerebral enlightenment. Under no circumstances should it be erroneously construed as a surrogate for sagacious medical discernment or the perspicacious adjudication of a licensed clinician. This platform does not purvey medical counsel, nor should its corpus be invoked for nosological determinations, curative stratagems, or any consequential healthcare resolutions. The expositions delineated herein are solely the intellectual purview of the respective authors and do not, in any capacity, embody the official imprimatur of any affiliated entity. The textual articulations, iconographic embellishments, and graphical constituents are scrupulously curated from august scholarly treatises and publicly accessible epistemic repositories. Notwithstanding our indefatigable endeavors to perpetuate the unimpeachable accuracy and contemporaneity of the medical intelligence imparted, we cannot incontrovertibly guarantee its seamless congruence with the perpetually evolving corpus of scientific advancement. In exigent or dire exigencies, one must expeditiously summon emergency medical intervention by dialing 911. For individuated and bespoke medical advisement, it is imperative to solicit the sagacious counsel of a duly credentialed physician. Under no vicissitude should professional medical advisement be abnegated, procrastinated, or supplanted by perusals of this website’s contents. Moreover, this platform neither extols nor promulgates particular nosological postulations, medical functionaries, remedial methodologies, pharmacological conglomerates, or doctrinaire therapeutic philosophies. By availing oneself of this website’s contents, the onus of securing veritable and authoritative medical counsel remains incontrovertibly vested in you. The website and its progenitors categorically repudiate any liability emergent from the construal, reliance upon, or extrapolation of its textual or visual constituents.

Copy Right @DharSaty

'O' My Dear LORD! Lead us, guide us, inspire us, and remind us to believe in possibilities.